NIR‐Triggered Organic Semiconductor Bulk Heterostructure Nanoparticles Enable Dual‐Mechanism Photodynamic Anti‐Tumor Therapy
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.71356 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Ying Huang und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Shandong Second Medical University, Weifang, Shandong, P. R. China. Hauptthemen laut MEDLINE: Photochemotherapy, Nanoparticles, Semiconductors, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Shandong Province Natural Science Foundation, Overseas Excellent Youth Science Fund project of Shandong Province, Taishan Scholar Foundation of Shandong Province.
Abstract (Originalsprache)
Low‐bandgap non‐fullerene acceptors (NFAs) predominantly generate a variety of reactive oxygen species (ROS) via the type‐I photodynamic process, a feature that renders them particularly advantageous for the treatment of hypoxic solid tumors. However, the hypoxic microenvironment typically arises during type‐I PDT can upregulate apoptosis‐suppressing genes and promote immunosuppression, thereby facilitating tumor cell survival, invasion, and metastasis. To address these limitations, we integrated the charge‐transport material PFN‐Br with an NFA (H1) to construct bulk heterostructured nanoparticles (H2 (10:1)@NPs). This structural design not only promoted J‐aggregation of H2‐NPs, but also enhanced their spin‐orbit coupling (SOC) through the external heavy‐atom effect, thereby facilitating efficient intersystem crossing (ISC) from the singlet excited state (S 1 ) to the triplet state (T 1 ). The resulting increase in the T 1 exciton augmented both charge and energy transfer, leading to a marked enhancement in type‐I and type‐II ROS production. Consequently, PFN‐Br as ROS amplifier within the bulk heterostructure, disrupting intracellular redox homeostasis and activating both apoptotic and pyroptotic cell death pathways to achieve pronounced antitumor efficacy. This study offers new strategic insights for advancing high‐performance photocatalytic tumor therapy toward clinical application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Shandong Second Medical University, Weifang, Shandong, P. R. China.
- College of Chemistry, Jilin University, Changchun, P. R. China.
- International Center of Future Science, Jilin University, Changchun, P. R. China.
- School of Life Science and Technology, Shandong Second Medical University, Weifang, Shandong, P. R. China.
- Affiliated Hospital of Shandong Second Medical University, School of Clinical Medicine, Shandong Second Medical University, Weifang, Shandong, P. R. China.
- Affiliated Hospital of Shandong Second Medical University, Shandong Second Medical University, Weifang, Shandong, P. R. China.
Förderung
- Shandong Province Natural Science Foundation
- Overseas Excellent Youth Science Fund project of Shandong Province
- Taishan Scholar Foundation of Shandong Province
- Natural Science Foundation of Shandong Province
Zitieren
APA
Huang, Y., Ma, S., He, Y., Yue, Y., Qiao, Z., Zeng, L., Wang, Y., Wang, Y. S., Qi, L., Zhou, J., Wang, B., & Zheng, B. (2026). NIR‐Triggered Organic Semiconductor Bulk Heterostructure Nanoparticles Enable Dual‐Mechanism Photodynamic Anti‐Tumor Therapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71356
Vancouver
Huang Y, Ma S, He Y, Yue Y, Qiao Z, Zeng L, et al. NIR‐Triggered Organic Semiconductor Bulk Heterostructure Nanoparticles Enable Dual‐Mechanism Photodynamic Anti‐Tumor Therapy. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.71356
BibTeX
@article{Huang2026,
author = {Huang, Ying and Ma, Shida and He, Yongrui and Yue, Yuchen and Qiao, Zihan and Zeng, Landi and Wang, Yaru and Wang, Ying-Shuai and Qi, Li and Zhou, Jin and Wang, Bin and Zheng, Bing},
title = {NIR‐Triggered Organic Semiconductor Bulk Heterostructure Nanoparticles Enable Dual‐Mechanism Photodynamic Anti‐Tumor Therapy},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.71356}
}
EUVIMED